BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5245 related articles for article (PubMed ID: 26771115)

  • 1. The Emerging Hallmarks of Cancer Metabolism.
    Pavlova NN; Thompson CB
    Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative fuels for cancer cells.
    Keenan MM; Chi JT
    Cancer J; 2015; 21(2):49-55. PubMed ID: 25815843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic role of natural compounds in mTOR-mediated metabolic reprogramming.
    Cerella C; Gaigneaux A; Dicato M; Diederich M
    Cancer Lett; 2015 Jan; 356(2 Pt A):251-62. PubMed ID: 24530513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Dependencies in RAS-Driven Cancers.
    Kimmelman AC
    Clin Cancer Res; 2015 Apr; 21(8):1828-34. PubMed ID: 25878364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic plasticity of cancer cells.
    Raudenská M; Peltanová B; Hönigová K; Navrátil J; Masařík M
    Klin Onkol; 2022; 35(3):195-207. PubMed ID: 35760572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways.
    Fumarola C; Petronini PG; Alfieri R
    Biochem Pharmacol; 2018 May; 151():114-125. PubMed ID: 29530507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of sirtuins family in cell metabolism during tumor development.
    Zhu S; Dong Z; Ke X; Hou J; Zhao E; Zhang K; Wang F; Yang L; Xiang Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():59-71. PubMed ID: 30453040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamentals of cancer metabolism.
    DeBerardinis RJ; Chandel NS
    Sci Adv; 2016 May; 2(5):e1600200. PubMed ID: 27386546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
    Lv J; Wang J; Chang S; Liu M; Pang X
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Signaling to the Nucleus in Cancer.
    Campbell SL; Wellen KE
    Mol Cell; 2018 Aug; 71(3):398-408. PubMed ID: 30075141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of metabolic genes and metabolites in cancer.
    Oermann EK; Wu J; Guan KL; Xiong Y
    Semin Cell Dev Biol; 2012 Jun; 23(4):370-80. PubMed ID: 22306135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming of the tumor.
    Ferreira LM; Hebrant A; Dumont JE
    Oncogene; 2012 Sep; 31(36):3999-4011. PubMed ID: 22231450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
    Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
    Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 263.